Citizens And 4 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed higher by more than 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and
Shareholder Alert: Ademi LLP Investigates Disclosure Issues Involving ARCA Biopharma, Inc.'s Transaction With Oruka
MILWAUKEE, June 4, 2024 /PRNewswire/ -- Ademi LLP is investigating ARCA (NASDAQ: ABIO) for possible breaches of fiduciary duty and other violations of law in its transaction with Oruka. Click here to
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersBio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 70.4% to $3.51 during Monday's pre-market session. The market value of their outstanding shares is at $5.8 million. Molecular Partners (NASDA
Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions to Comply With IVDR Regulation
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAkanda (NASDAQ:AKAN) shares increased by 103.8% to $0.27 during Friday's regular session. The company's market cap stands at $8.6 million. NovaBay Pharmaceuticals (AMEX:NBY) shares rose 48.66%
GameStop Trader 'Roaring Kitty' Sparks Wall Street Rally In Heavily Shorted Stocks: What You Need To Know Right Now
Several stocks with high short interest rallied on Monday following an incredible surge in GameStop shares. Here's a quick look at what you need to know.
Express News | ARCA Biopharma Inc- Qtrly Net Loss 0.14 per Basic and Diluted Share
Express News | ARCA Biopharma Inc - G&a Expenses in 2024 Are Expected to Be Higher Than Those in 2023
Express News | ARCA Biopharma Inc - Expect to Continue to Incur Costs and Expenditures in Connection With Process of Evaluating Strategic Alternatives
Express News | ARCA Biopharma- Future Viability Beyond Middle of 2025 Is Dependent on Results of Strategic Review Process, Ability to Raise Additional Capital
Express News | ARCA Biopharma Inc - Cash and Cash Equivalents Will Be Sufficient to Fund Its Operations Through Middle of 2025
Express News | ARCA Biopharma Inc - Cash and Cash Equivalents Were $35.9 Mln as of March 31, 2024
Express News | ARCA Biopharma Inc - Strategic Alternatives Including, Without Limitation, Licensing Transactions and Asset Sales
Express News | ARCA Biopharma Inc - Company Has and Is Continuing to Explore Strategic Alternatives Related to Its Product Candidates and Related Assets
Express News | ARCA Biopharma Q1 EPS $(0.14) Down From $(0.09) YoY
Express News | ARCA Biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
ARCA Biopharma 1Q Loss $2.01M >ABIO
ARCA Biopharma 1Q Loss $2.01M >ABIO
Arca Biopharma Increases Executive Retention Bonuses
Thermo Fisher Scientific Innovations at Analytica 2024 Optimize Workflows and Enable Precise Analysis Across Life Sciences, Applied and Industrial Markets
Express News | ARCA Biopharma 13D Filing Shows Adage Capital Management, L.P. Reported A 8.28% Stake In The Co As Of April 3, 2024